**Core Concept:** Fetal hydantoin syndrome is a group of developmental abnormalities seen in newborns exposed to antiepileptic drugs, particularly those in the hydantoin class, during pregnancy. The syndrome includes physical, neurological, and developmental impairments.

**Why the Correct Answer is Right:** Fetal hydantoin syndrome is associated with the use of antiepileptic drugs, specifically hydantoins, in pregnant women. The correct answer, **D**, refers to the drug hydantoin sodium, a potent anticonvulsant used to control seizures in pregnant women. However, the use of these drugs can lead to significant developmental abnormalities in the exposed fetus.

**Why Each Wrong Option is Incorrect:**

A. **Option A (Phenobarbital):** Although phenobarbital is also an anticonvulsant, it is not as strongly associated with fetal abnormalities as the hydantoins.

B. **Option B (Valproic acid):** While valproic acid is also used in epilepsy management, it is less commonly linked to the development of fetal hydantoin syndrome.

C. **Option C (Levetiracetam):** Levetiracetam is a newer antiepileptic drug that is generally considered safe for use during pregnancy, making it less likely to cause fetal hydantoin syndrome.

**Clinical Pearl / High-Yield Fact:** The risk of fetal hydantoin syndrome is higher with the use of hydantoins like hydantoin sodium (option D) compared to other antiepileptic drugs. Healthcare providers must weigh the benefits of seizure control against the potential risks to the unborn child when deciding on a treatment plan for pregnant women with epilepsy.

**Correct Answer:** D. Hydantoin sodium